Literature DB >> 18454264

Oxidative stress in the blood of patients with active localized vitiligo.

Ozer Arican1, Ergül Belge Kurutas.   

Abstract

OBJECTIVES: Vitiligo is an acquired skin disease characterized by white areas on the skin. The pathogenesis of the disease is still unclear. Some findings show that oxidative stress could be an important phenomenon in the pathophysiology of vitiligo.
METHODS: We evaluated 16 consecutive localized vitiligo patients and 16 healthy controls of a similar age and sex distribution. We measured their indicators of oxidative stress such as catalase (CAT), superoxide dismutase (SOD), glucose 6-phosphate dehydrogenase (G6PD) in erythrocytes, and plasma malondialdehyde (MDA) by spectrophotometry.
RESULTS: SOD activities and MDA levels of patients were significantly higher than controls (p < 0.001). CAT and G6PD activities of patients were significantly lower than controls (p < 0.05 and p < 0.001, respectively).
CONCLUSION: Our results confirmed that oxidative stress may play an important role in the pathogenesis of vitiligo. Melanocyte damage in vitiligo might be linked to generalized oxidative stress. This study is the first report on some antioxidant parameters of localized-type vitiligo patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18454264

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  12 in total

1.  Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo.

Authors:  Yasser E Elassiuty; Jared Klarquist; Jodi Speiser; Randa M Yousef; Abdelaziz A El Refaee; Nahla S Hunter; Olfat G Shaker; Mohan Gundeti; Ludmila Nieuweboer-Krobotova; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2011-03-22       Impact factor: 3.960

2.  Reduced serum paraoxonase-1 levels in vitiligo: further evidence of oxidative stress.

Authors:  Yavuz Yesilova; Enver Turan; Derya Ucmak; Sahabettin Selek; İbrahim Halil Yavuz; Osman Tanrıkulu
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

3.  Decreased glucose-6-phosphate dehydrogenase levels in vitiligo patients: Further evidence of oxidative stress.

Authors:  Amir Farahi-Jahromy; Mohammad Kazem Fallahzadeh; Soheil Ashkani-Esfahani; Nasrin Hamidizadeh; Mahsa Ghavipisheh; Mohammad Reza Namazi
Journal:  Adv Biomed Res       Date:  2014-01-09

4.  Association between Vitiligo and Thyroid Autoimmunity.

Authors:  Emina Kasumagic-Halilovic; Asja Prohic; Begler Begovic; Nermina Ovcina-Kurtovic
Journal:  J Thyroid Res       Date:  2011-05-04

5.  What is the important practical implication of detecting decreased G6PD levels in vitiligo?

Authors:  Mohammad Reza Namazi
Journal:  Adv Biomed Res       Date:  2015-05-11

6.  Study of oxidative stress in peripheral blood of Indian vitiligo patients.

Authors:  Sudha S Deo; Ameya R Bhagat; Rajnikant N Shah
Journal:  Indian Dermatol Online J       Date:  2013-10

Review 7.  Oxidative stress and immune system in vitiligo and thyroid diseases.

Authors:  Roberta Colucci; Federica Dragoni; Silvia Moretti
Journal:  Oxid Med Cell Longev       Date:  2015-03-09       Impact factor: 6.543

8.  Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients.

Authors:  Gülcan Güntaş; Burhan Engin; Özlem Balcı Ekmekçi; Zekayi Kutlubay; Hakan Ekmekci; Abdullah Songür; Tuğba Kevser Üstünbaş Uzunçakmak; Hayriye Ertem Vehid; Server Serdaroğlu; Yalçın Tüzün; Hafize Uzun
Journal:  Ann Dermatol       Date:  2015-03-24       Impact factor: 1.444

9.  The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study.

Authors:  Farahnaz Fatemi Naini; Alireza Vaez Shooshtari; Bahareh Ebrahimi; Razieh Molaei
Journal:  J Res Pharm Pract       Date:  2012-10

10.  Analysis of oxidative stress status, catalase and catechol-O-methyltransferase polymorphisms in Egyptian vitiligo patients.

Authors:  Dina A Mehaney; Hebatallah A Darwish; Rehab A Hegazy; Mohammed M Nooh; Amira M Tawdy; Heba I Gawdat; Maha M El-Sawalhi
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.